Anti-Mouse EpCAM (CD326) [Clone G8.8] — Purified in vivo GOLDTM Functional Grade
Anti-Mouse EpCAM (CD326) [Clone G8.8] — Purified in vivo GOLDTM Functional Grade
Product No.: C724
Clone G8.8 Target CD326 Formats AvailableView All Product Type Hybridoma Monoclonal Antibody Alternate Names EGP314 Isotype Rat IgG2a κ Applications FC , IF , IHC , IP , WB |
Antibody DetailsProduct DetailsReactive Species Mouse Host Species Rat Recommended Isotype Controls Recommended Isotype Controls Recommended Dilution Buffer Immunogen TE-71 thymic epithelial cell line Product Concentration ≥ 5.0 mg/ml Endotoxin Level < 1.0 EU/mg as determined by the LAL method Purity ≥95% by SDS Page ⋅ ≥95% monomer by analytical SEC Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. State of Matter Liquid Product Preparation Functional grade preclinical antibodies are manufactured in an animal free facility using only in vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. Regulatory Status Research Use Only Country of Origin USA Shipping 2-8°C Wet Ice Additional Applications Reported In Literature ? IHC, IF, FC, IP, WB Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity G8.8 activity is directed against mouse EpCAM (CD326) and does not recognize human or rat EpCAM. Background Epithelial cell adhesion molecule (EpCAM; also known as CD326 or Tacstd1) is a 40 kDa type I transmembrane glycoprotein composed of an extracellular domain, single transmembrane domain, and the intracellular domain Ep1CD1. EpCAM functions in cell adhesion, signaling, differentiation, migration, proliferation, formation and maintenance of organ morphology, and morphogenic movements during gastrulation. Additionally, EpCAM is essential for cell junctions; the AxxxG motif in the transmembrane domain of EpCAM associates directly with claudin-7, an important tight junction protein. EpCAM also suppresses or enhances E-cadherin function depending on the context of the interaction. Mutant animal models have been developed in mouse (at least four global EpCAM knockout types and one conditional knockout), zebrafish, and Xenopus. Dysregulation and/or mutations are associated with congenital tufting enteropathy (CTE), which causes lethal diarrhea in newborns, cholestatic liver diseases, and cancer1. EpCAM promotes the proliferation of tumors, is involved in tumorigenesis and metastasis, and EpCAM positive cells serve as cancer stem cells for various human cancers. Therapeutic approaches targeting EpCAM are under development to eliminate chemotherapeutic drug resistance in cancer stem cells by conjugating cancer stem cells targeting EpCAM aptamer with a chemotherapeutic drug. Additionally, EpCAM antibody sensitizes chemoresistant myeloid leukemia to innate immune cells, and EpCAM peptide-primed dendritic cell vaccinations exhibit anti-tumor immunity in hepatocellular carcinoma cells. Monoclonal antibody G8.8 was raised against glycoconjugates isolated from the TE-71 mouse thymic epithelial cell line2. Splenic cell suspensions were fused with X63-Ag8.653 cells and the resulting hybridomas were screened on frozen Balb/c thymus. Antigen Distribution EpCAM is expressed in many epithelial tissues from very early embryos to adult animals and is a cell surface marker on various stem and progenitor cells. EpCAM is also an important carcinoma marker highly expressed on a variety of carcinomas, including epithelial tumors and acute myeloid leukemia. EpCAM is enriched in the basolateral membrane of mouse and human intestinal epithelium and is localized to tight junctions, adherens junctions, and the lateral membranes of epithelial cells lining the intestines. Ligand/Receptor LAIR-1 (CD305) and LAIR-2 (CD306) NCBI Gene Bank ID UniProt.org Research Area Cell Adhesion . Immunology Leinco Antibody AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. Clone G8.8 is a rat monoclonal antibody specific to mouse EpCAM (CD326) that is widely used in in vivo mouse studies primarily to identify, isolate, and study epithelial cells and thymic epithelial cells. Key uses in in vivo mouse studies include:
Additional essential details:
In summary, clone G8.8 is a standard reagent for marking, isolating, and studying mouse epithelial and thymic epithelial cell populations in vivo and ex vivo across a variety of experimental applications. I don't have specific information about the storage temperature requirements for sterile packaged clone G8.8 in the provided search results. The search results contain general storage guidelines for various biological materials and laboratory reagents, but none specifically mention clone G8.8 or its storage requirements. The search results do provide storage temperatures for other laboratory materials: plasmid vectors are typically stored at -20°C, virus stocks require -80°C storage, and certain enzyme mixes can be stored at -20°C for short term (6 months) or -80°C for long-term storage. However, without specific information about clone G8.8 - including what type of biological material it is, how it's packaged, and manufacturer specifications - I cannot determine the correct storage temperature. For accurate storage requirements for clone G8.8, you should consult the manufacturer's documentation, product insert, or contact the supplier directly, as storage conditions can vary significantly depending on the specific type of clone, its formulation, and packaging. The G8.8 antibody is most commonly used to detect EpCAM (CD326), and in the literature, it is frequently employed alongside several other antibodies and proteins depending on the specific research context. Commonly used antibodies/proteins with G8.8:
Examples from literature:
In summary, the most common companion antibodies or proteins used with G8.8 in published research are immune cell markers, other epithelial cell markers, and enzyme or reporter conjugateswith the specific choices tailored to the experimental goals and techniques used in each study. Clone G8.8 is a well-established rat monoclonal antibody that targets the mouse epithelial cell adhesion molecule (EpCAM/CD326), and its citations in scientific literature have contributed to several important findings across multiple research areas. Primary Antibody Characteristics and ApplicationsThe G8.8 clone was deposited to the Developmental Studies Hybridoma Bank by Farr, A.G. from the University of Washington in 1997. This antibody specifically recognizes mouse EpCAM but notably does not cross-react with human or rat EpCAM, making it highly species-specific. The antibody has proven versatile across multiple experimental techniques, with confirmed applications including flow cytometry (FACS), immunofluorescence, immunohistochemistry, immunoprecipitation, and Western blotting. Thymic Epithelial Cell ResearchOne of the most significant applications of G8.8 has been in thymic epithelial cell purification and characterization. The antibody has been successfully used to isolate and purify thymic epithelial cells, which are crucial components of the thymic microenvironment responsible for T cell development and selection. This application has been particularly valuable for researchers studying immune system development and thymic function. Cancer Research ApplicationsRecent citations demonstrate G8.8's utility in cancer-associated fibroblast (CAF) research, particularly in pancreatic ductal adenocarcinoma (PDAC) studies. The antibody has been employed in cross-species single-cell analyses that revealed important insights about antigen-presenting cancer-associated fibroblasts. These studies utilized G8.8 in conjunction with other markers to characterize different CAF subtypes and their roles in tumor microenvironments. Immunological Function StudiesThe literature shows that G8.8 has contributed to understanding antigen presentation mechanisms in cancer contexts. Research using this antibody has helped identify CAF populations capable of presenting antigens to CD4+ T cells, demonstrating that certain cancer-associated fibroblasts can function as non-professional antigen-presenting cells. These findings have implications for understanding how tumors modulate immune responses. Technical Methodological ContributionsCitations of G8.8 have established important methodological protocols for EpCAM-based cell sorting and analysis. The antibody's reliable performance in flow cytometry applications has made it a standard tool for identifying and isolating EpCAM-positive cell populations in mouse models. Its use in immunohistochemistry applications, particularly with acetone-fixed frozen sections, has provided researchers with consistent staining protocols. The extensive citation history of clone G8.8 reflects its value as a research tool that has enabled discoveries spanning developmental immunology, cancer biology, and cellular characterization methodologies, establishing it as a reliable reagent for mouse EpCAM detection across diverse experimental contexts. References & Citations1. Huang L, Yang Y, Yang F, et al. Int J Mol Med. 42(4):1771-1785. 2018. 2. Farr A, Nelson A, Truex J, et al. J Histochem Cytochem. 39(5):645-653. 1991. 3. Li H, Hsu HC, Wu Q, et al. Nat Commun. 5:4259. 2014. 4. Wang J, Wang D, Chu K, et al. Nat Commun. 10(1):4966. 2019. 5. Martínez LE, Garcia G Jr, Contreras D, et al. J Virol. 94(9):e00067-20. 2020. 6. Petersen B, Wolf M, Austermann J, et al. EMBO J. 32(1):100-111. 2013. 7. Snitow M, Lu M, Cheng L, et al. Development. 143(20):3733-3741. 2016. 8. Kazakevych J, Denizot J, Liebert A, et al. Genome Biol. 21(1):64. 2020. 9. Maaser K, Borlak J. Br J Cancer. 99(10):1635-1643. 2008. 10. Kuan II, Liang KH, Wang YP, et al. Sci Rep. 7:41852. 2017. 11. Kuroki S, Maeda R, Yano M, et al. Stem Cell Reports. 15(2):424-438. 2020. 12. Papadopoulou AS, Dooley J, Linterman MA, et al. Nat Immunol. 13(2):181-187. 2011. 13. Goldman O, Han S, Sourisseau M, et al. Cell Stem Cell. 12(6):748-760. 2013. 14. Shim EJ, Bang BR, Kang SG, et al. J Immunol. 191(5):2764-2770. 2013. 15. de Jong JH, Rodermond HM, Zimberlin CD, et al. Sci Rep. 2:271. 2012. 16. Liu Z, Guo W, Zhang D, et al. Sci Rep. 6:39808. 2016. 17. Freire T, Zhang X, Dériaud E, et al. Blood. 116(18):3526-3536. 2010. 18. Naus S, Blanchet MR, Gossens K, et al. Am J Respir Crit Care Med. 181(12):1318-1328.2010. 19. Cook BD, Liu S, Evans T. Blood. 16;117(24):6489-6497. 2011. 20. Krishnamurthy B, Chee J, Jhala G et al. Diabetes. 61(2):425-435. 2012. 21. El-Zaatari M, Kao JY, Tessier A, et al. PLoS One. 8(3):e58935. 2013. 22. Magness ST, Puthoff BJ, Crissey MA, et al. Am J Physiol Gastrointest Liver Physiol.305(8):G542-551. 2013. 23. Tata PR, Mou H, Pardo-Saganta A, et al. Nature. 503(7475):218-223. 2013. 24. Fischedick G, Wu G, Adachi K, et al. Stem Cell Res. 13(2):300-315. 2014. 25. Velardi E, Tsai JJ, Holland AM, et al. J Exp Med. 211(12):2341-2349. 2014. 26. Clatworthy MR, Aronin CE, Mathews RJ, et al. Nat Med. 20(12):1458-1463. 2014. 27. Thelemann C, Eren RO, Coutaz M, et al. PLoS One. 9(1):e86844. 2014. 28. Walmsley GG, Rinkevich Y, Hu MS, et al. Tissue Eng Part C Methods. 21(3):314-321. 2015. 29. Xia H, Ren X, Bolte CS, et al. Am J Respir Cell Mol Biol. 52(5):611-621. 2015. 30. Goto Y, Lamichhane A, Kamioka M, et al. Sci Rep. 5:15918. 2015. 31. Satoh R, Kakugawa K, Yasuda T, et al. PLoS Genet. 12(1):e1005776. 2016. 32. Shi Y, Wu W, Chai Q, et al. Nat Commun. 7:12369. 2016. 33. Cuccarese MF, Dubach JM, Pfirschke C, et al. Nat Commun. 8:14293. 2017. 34. Yamaji M, Jishage M, Meyer C, et al. Nature. 543(7646):568-572. 2017. 35. Lim JS, Ibaseta A, Fischer MM, et al. Nature. 545(7654):360-364. 2017. 36. Lopes N, Vachon H, Marie J, et al. EMBO Mol Med. 9(6):835-851. 2017. 37. Nikolaidis NM, Noel JG, Pitstick LB, et al. Proc Natl Acad Sci U S A. 114(32):E6613-E6622.2017 38. Koh AS, Miller EL, Buenrostro JD, et al. Nat Immunol. 19(2):162-172. 2018. 39. Lopes N, Charaix J, Cédile O, et al. Nat Commun. 9(1):1262. 2018. 40. Moretti FA, Klapproth S, Ruppert R, et al. Elife. 7:e35816. 2018. 41. Thilakasiri P, Huynh J, Poh AR, et al. EMBO Mol Med. 11(4):e9539. 2019. 42. Glal D, Sudhakar JN, Lu HH, et al. Front Immunol. 9:2522. 2018. 43. Wang X, Yang L, Wang YC, et al. Cell Res. 30(12):1109-1126. 2020. 44. Giraud J, Foroutan M, Boubaker-Vitre J, et al. Transl Oncol. 14(2):101001. 2021. 45. Goga A, Yagabasan B, Herrmanns K, et al. Nat Commun. 12(1):3339. 2021. 46. Mauduit O, Aure MH, Delcroix V, et al. Cell Rep. 39(2):110663. 2022. 47. Ferreirinha P, Pinheiro RGR, Landry JJM, et al. Development. 149(10):dev200513. 2022. Technical ProtocolsCertificate of Analysis |
Related Products
Formats Available
Prod No. | Description |
---|---|
C735 | |
C729 | |
C730 | |
C728 | |
C726 | |
C724 | |
C731 | |
C732 | |
C733 | |
C734 | |
C725 |
